Skip to main content
ALCIDION GROUP LIMITED logo

ALCIDION GROUP LIMITED — Investor Relations & Filings

Ticker · ALC ISIN · AU000000ALC6 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 728 across all filing types
Latest filing 2026-05-24 Regulatory Filings
Country AU Australia
Listing ASX ALC

About ALCIDION GROUP LIMITED

https://www.alcidion.com

Alcidion Group Limited develops and delivers specialized software solutions designed to enhance patient safety and clinical productivity. The company’s core offering, Miya Precision, is an interoperable platform that consolidates data from disparate clinical systems to provide real-time insights, clinical decision support, and predictive analytics. Complementary products include Patientrack, which automates the monitoring of patient vitals and early warning scores, and Smartpage, a secure clinical communication and task management system. These integrated technologies facilitate digital transformation within hospital environments by streamlining workflows and reducing clinical risk. The company focuses on providing healthcare providers with actionable data to improve care delivery and operational efficiency.

Recent filings

Filing Released Lang Actions
ALC signs 7-year contract with UHSussex for EPR platform 2 pages 281.3KB
Regulatory Filings Classification · 80% confidence The document is an ASX company announcement detailing a new customer contract and partner agreement for an EPR platform. It contains no financial statements, no fundraising or financing details, no board changes, no voting results, no share issues or buybacks, and no dividend. It is not an earnings release or report publication announcement, but a miscellaneous corporate update filed with the regulator. Therefore, it falls under Regulatory Filings (RNS) as the catch-all for general regulatory announcements.
2026-05-24 English
Acquisition of the Kyra flow products from Telstra Health 4 pages 285.2KB
M&A Activity Classification · 90% confidence The document is an ASX announcement detailing Alcidion’s acquisition of the Kyra flow products from Telstra Health, including transaction structure, strategic rationale, financial impacts, and funding. This clearly describes an M&A transaction rather than a routine earnings release, board change announcement, or financial report. Therefore, it falls under M&A Activity (Code: TAR).
2026-05-17 English
Q3 FY26 Quarterly Activities Report and Appendix 4C 8 pages 598.0KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q3 FY26 Quarterly Activities Report' and includes detailed financial data such as cash flow statements, revenue figures, operating cash flow, and contract updates for the quarter ended 31 March 2026. It references Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules. The content includes substantive financial data and analysis for a quarter, not just an announcement or summary. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-04-28 English
Alcidion Q3 FY26 Results and Investor Webcast Notification 2 pages 260.4KB
Report Publication Announcement Classification · 87% confidence The document is a short ASX release (under 5,000 characters) notifying investors of the timing for the release of the company’s Appendix 4C Quarterly Cash Flow Report for Q3 FY26 and inviting them to a webcast. It does not contain the actual financial results or detailed analysis, but rather announces when and how the report and webcast will be published. This fits the definition for a Report Publication Announcement (RPA).
2026-04-21 English
H1 FY26 Appendix 4D and Half Year Report 23 pages 1.3MB
Interim / Quarterly Report Classification · 100% confidence The document is titled "Appendix 4D & Financial statements for the period ended 31 December 2025" and includes detailed financial information for the half-year ended 31 December 2025. It contains comprehensive financial statements such as the Consolidated Statement of Profit or Loss, Statement of Financial Position, Statement of Changes in Equity, and Cash Flows, along with Directors' Report and Auditor's Review Report. The reporting period is explicitly a half-year period, and the document includes substantive financial data and analysis, not just an announcement or summary. The presence of an auditor's review report further confirms this is a half-year financial report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-02-25 English
H1 FY26 Results Release 5 pages 281.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'H1 FY26 Results' and provides detailed financial results for the six months ending 31 December 2025, including revenue, EBITDA, NPAT, ARR, and cash balance. It also includes business updates, customer contract expansions, product development, and outlook for the full fiscal year 2026. The document contains substantive financial data and analysis for a half-year period, which aligns with the definition of an Interim / Quarterly Report (IR). It is not a brief announcement or a certification, but a comprehensive financial report for a period shorter than a full fiscal year. Therefore, the appropriate classification is 'IR'.
2026-02-25 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.